Grantclosed🌐 United StatesPAR-25-099

Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: Dec 30, 2024
Response deadline: Feb 19, 2026, 12:00 AM UTC
Type: Grant
Category: 93.855
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-25-099

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
United States · Oct 1, 2024
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Not Allowed)
United States · Jun 28, 2024
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
United States · Sep 24, 2025
Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Disease (R01 Clinical Trial Not Allowed)
United States · Aug 26, 2025

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.